Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trials
    • Xep01
    • Xep02
  • News
    • See news
    • Press
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trials
    • Xep01
    • Xep02
  • News
    • See news
    • Press
  • Blog
  • Contact

NEWS

Celebrating Excellence: Dr. Luis Barbeito Wins the National Science Grand Prize 2024
Xeptiva Therapeutics raised $2.5M seed round
The first industrial batch of our vaccine has been produced!
New government grant for Xeptiva Therapeutics
Institut Pasteur de Montevideo & Xeptiva Therapeutics
Pasaporte Emprendedor
WeXchange
New Government Grant for Xeptiva Therapeutics
Government Grant for Xeptiva Therapeutics and the Institut Pasteur de Montevideo
Xeptiva Therapeutics, a biotech startup born in the Institut Pasteur de Montevideo, advances in its development
World Neuroscience Organization awards Emiliano Trías, a Uruguayan scientist, with the IBRO Young Investigator Award 2021

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

clinical trial

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2025.  ALL RIGHTS RESERVED.